Fortrea Development India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-11-2024
- Paid Up Capital ₹ 0.51 M
as on 03-11-2024
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 21.40%
(FY 2023)
- Profit 83.76%
(FY 2023)
- Ebitda 34.89%
(FY 2023)
- Net Worth 54.71%
(FY 2023)
- Total Assets 33.15%
(FY 2023)
About Fortrea Development India
The Corporate was formerly known as Labcorp Drug Development Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.51 M, as per Ministry of Corporate Affairs (MCA) records.
Rangarajan Narasimhan, Rishi Sharma, and David Cooper serve as directors at the Company.
- CIN/LLPIN
U74999KA2007PTC190095
- Company No.
172206
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Jul 2007
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fortrea Development India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rangarajan Narasimhan  | Director | 24-Jul-2020 | Current |
| Rishi Sharma | Director | 11-Sep-2023 | Current |
David Cooper  | Director | 30-Jun-2023 | Current |
Financial Performance and Corporate Structure Insights of Fortrea Development India.
Fortrea Development India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.4% increase. The company also saw a substantial improvement in profitability, with a 83.76% increase in profit. The company's net worth Soared by an impressive increase of 54.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fortrea Development India?
In 2023, Fortrea Development India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fortrea Scientific Private LimitedActive 17 years 8 monthsRangarajan Narasimhan, Rishi Sharma and 1 more are mutual person
Fortrea Clinical Development Private LimitedActive 22 years 2 monthsRangarajan Narasimhan, Rishi Sharma and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Fortrea Development India?
Fortrea Development India has a workforce of 3153 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fortrea Development India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fortrea Development India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
